Abstract 1846P
Background
Confronting breast cancer diagnosis, alongside with complex and challenging treatment procedures comprise an extremely stressful experience. Psychological resilience (PR) is the ability to maintain or restore normal functioning while facing the adversity, leading to better quality of life and preventing stress-related health conditions in cancer patients. We aimed to investigate the impact of early breast cancer (EBC) diagnosis on PR, distress and perception of health.
Methods
Case-controlled study included 50 newly diagnosed EBC patients and 67 women without breast cancer whose screening mammography was graded by Breast imaging-reporting and data system 1 and 2. The level of distress, perception of health and PR were assessed using the Depression Anxiety and Stress Scale 21, SF 36-Item Health Survey 1.0 and Connor-Davidson RISC-25 scale. EBC patients were questioned after confronting EBC diagnosis and before starting the treatment.
Results
The EBC patients reported deterioration of health, compared to previous year (t (df) 3,835, p<0.01), while there were no differences between groups related to general and emotional health. There was no significant statistical difference between groups regarding the levels of depression, anxiety and stress. Majority of the EBC patients and controls, 66% and 82%, had no symptoms of depression, while severe depression was noted in 10% and 3%, respectively. Around 78% EBC patients and 89% controls didn't show any anxiety. Still, 8% EBC patients and 4.5% controls were severely anxious, and 10% EBC and 4% controls were severely stressed. And finally, regarding resilience, EBC patients showed significantly higher levels of PR than healthy control (t(df) 2,530, p<0.05).
Conclusions
Confronting EBC diagnosis, possibly leads to activation of intra-individual coping mechanisms and dynamic processes of effective adaptation leading to higher PR levels of EBC patients compared with healthy controls. Further research of PR should be encouraged, by investigating the mechanisms that protect individuals and prevent stress-related health conditions, resilience research shifts a paradigm from a disease-oriented to health-oriented and focuses on mechanisms that prevent stress-related disorders.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2018P - Novel nomogram based on the expression of DLL3 and PD-L1 for predicting the prognosis of small cell lung cancer patients
Presenter: Jun Zhao
Session: Poster session 05
2019P - Analysis of lung immune prognostic index (LIPI) score in a small cell lung cancer carcinoma (SCLC) cohort, supporting its prognostic use and investigating its predictive potential
Presenter: Mónica Esteban García
Session: Poster session 05
2020P - Circulating micro RNAs (cmiRNAs) as treatment outcome predictors in extensive small cell lung cancer (eSCLC) patients (pts) receiving atezolizumab plus carboplatin and etoposide (ACE): CATS/ML43257 study
Presenter: Giulia Pasello
Session: Poster session 05
2021P - Cell-free (cf) DNA as predictive biomarker (B) of treatment outcome in extensive small cell lung cancer (eSCLC) patients (pts) receiving atezolizumab, carboplatin and etoposide (ACE): CATS/ML43257 study
Presenter: Giulia Pasello
Session: Poster session 05
2022P - ALBA project: Prognostic impact of laterality in small cell lung cancer
Presenter: Lorenza Landi
Session: Poster session 05
2024P - Supportive measures to control myelosuppression and costs for patients with SCLC with lurbinectedin, CAV or topotecan with or without trilaciclib: A review on the basis of clinical trials
Presenter: Manuel Dómine
Session: Poster session 05
2025P - Stratified control study of neuroendocrine differentiation and potential clinicopathologic markers
Presenter: Li Liu
Session: Poster session 05
2026P - Small cell lung cancer (SCLC) in the KBP-2020-CPHG cohort and comparison with 2000 and 2010
Presenter: Lionel Falchero
Session: Poster session 05
2027P - Immune checkpoint inhibitors in the treatment of small cell lung cancer: A systematic review and meta-analysis
Presenter: Patsy Lee
Session: Poster session 05